Clinical Oncology: Year 2019 in Review
The clinical practice of oncology is a rapidly-evolving discipline. This program will provide physicians – especially oncologists, gynecologic oncologists, hematologists, radiation oncologists, and surgical oncologists – as well as cancer-interested dermatologists, gastroenterologists, nephrologists, pulmonologists, urologists, nurse practitioners and physician assistants, with a summary of the latest advances in discipline-related cancers. New therapeutic agents will be a topic of discussion. This program will focus on how these new advances will impact the practice of oncology today.
Shipra Gandhi, MD, provides updates on neoadjuvant, adjuvant and metastatic therapies for the treatment of HER2-positive breast cancer, hormone receptor positive breast cancer, and triple negative breast cancer.
Christos Fountzilas, MD, discusses updates in GI malignancies. This lecture covers esophagogastric cancer, pancreatic cancer, colorectal cancer, neuroendocrine tumors, hepatocellular carcinoma and cholangiocarcinoma.
Out of the many of new drugs in development, Igor Puzanov, MD, MSCI, FACP, selected those that seem the most promising. In this lecture he will discuss the novel classes of promising agents in development, how to enhance immune response ...
Edwin Yau, MD, PhD, discusses metastatic lung cancers and provides updates on new FDA approvals.